Dr. Hoyun Lee and his team are involved in studying the fundamentals of science as well as more clinically oriented projects.

On the fundamental side, the Lee group focuses on unravelling how cancer and normal cells copy their genetic materials (i.e., DNA). Although this subject aims to understand the regulatory mechanism of human cells, knowledge obtained from this study can provide tremendous insight into the control of cancer in the future. The clinical projects in Dr. Lee’s laboratory are directly related to developing effective and safe anticancer drugs.

Dr. Lee completed his Masters in Microbiology and his PhD in Molecular Virology at the University of Guelph. He was awarded his postdoctoral fellowship in Biochemistry and Genetics at the University of Virginia, where he trained in the area of cell cycle regulation. In 1995, Dr. Lee was appointed to the rank of Assistant Professor in the Department of Radiation Oncology at the University of Virginia where he worked until he became a Junior Scientist and joined the Tumour Biology Group at the Northeast Cancer Center in 1996.

Currently, he is a Senior Scientist and holds Full Professor positions at the Northern Ontario School of Medicine and the University of Ottawa Medical School. Ten researchers and students are currently working in the Lee laboratory: four postdoctoral fellows/Research Associate, three graduate students, and two undergraduate students. Two additional graduate students are also slated to join the Lee research group in 2010.

May 29, 2014: One of Dr Hoyun Lee’s papers published in the European Journal of Pharmacology (EJP) in December 2009 was identified as the top article in the List of Top 25 Most Cited Articles in the EJP during the last five years.

Cure for cancer could be ‘in backyard’ – The Sudbury Star